Sign inJoin waitlistJoin the waitlist

Shishir Maithel

Chief of Surgical Oncology in the Department of Surgery · McGaw Medical Center of Northwestern University

Credentials: · · · · · ·

History

Surgical Oncology in the Department of Surgery Division · McGaw Medical Center of Northwestern University
Present
McGaw Medical Center of Northwestern University
Present
McGaw Medical Center of Northwestern University
Present

Complex General Surgical Oncology
Memorial Sloan Kettering Cancer Center
2007–2009
Beth Israel Deaconess Medical Center
2000–2007
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
1996–2000

Research

Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology
Review · Current Anthropology · 2017 · 500 citations
Gallbladder cancer
Review · Nature Reviews Disease Primers · 2022 · 348 citations
Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline
Systematic review or meta-analysis · Journal of Clinical Oncology · 2019 · Last of 13 authors · 346 citations

Timothy Pawlik
277 papers
George Poultsides
274 papers
Ryan Fields
177 papers
David Kooby
171 papers
Sharon Weber
149 papers
Todd Bauer
121 papers
Charles Staley
95 papers
Clifford Cho
91 papers
Kamran Idrees
83 papers · 23 as a resident
Kenneth Cardona
80 papers · 4 as a fellow
Juan Sarmiento
77 papers · 7 as a resident
Carl Schmidt
75 papers

Clinical trials

Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial
Principal investigator · Not yet recruiting · Phase 2
Northwestern University
2027–2031
Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer
Principal investigator · Active not recruiting · Phase 2, Phase 3
ECOG-ACRIN Cancer Research Group
2021–2029
Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer
Principal investigator · Withdrawn · Phase 3
Emory University
2019–2020
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer
Principal investigator · Completed · Phase 2
Emory University
2018–2023